These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 23434923

  • 1. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M, Chokshi H, Tang K, Parrott NJ, Reppas C, Dressman JB.
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
    Henze LJ, Koehl NJ, Jansen R, Holm R, Vertzoni M, Whitfield PD, Griffin BT.
    Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
    [Abstract] [Full Text] [Related]

  • 3. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
    Kalantzi L, Persson E, Polentarutti B, Abrahamsson B, Goumas K, Dressman JB, Reppas C.
    Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
    [Abstract] [Full Text] [Related]

  • 4. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
    Fuchs A, Leigh M, Kloefer B, Dressman JB.
    Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
    [Abstract] [Full Text] [Related]

  • 5. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
    Litou C, Vertzoni M, Xu W, Kesisoglou F, Reppas C.
    Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
    [Abstract] [Full Text] [Related]

  • 6. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y, Jantratid E, Kesisoglou F, Reppas C, Dressman JB.
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [Abstract] [Full Text] [Related]

  • 7. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y, Jantratid E, Dressman JB.
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [Abstract] [Full Text] [Related]

  • 8. Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities.
    Pedersen PB, Vilmann P, Bar-Shalom D, Müllertz A, Baldursdottir S.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):958-65. PubMed ID: 23727368
    [Abstract] [Full Text] [Related]

  • 9. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A, Blume H, Dressman J.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H, Löbenberg R.
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y, Kostewicz ES, Sheu MT, Dressman JB.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [Abstract] [Full Text] [Related]

  • 13. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
    Fagerberg JH, Tsinman O, Sun N, Tsinman K, Avdeef A, Bergström CA.
    Mol Pharm; 2010 Oct 04; 7(5):1419-30. PubMed ID: 20507160
    [Abstract] [Full Text] [Related]

  • 14. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
    Ottaviani G, Wendelspiess S, Alvarez-Sánchez R.
    Mol Pharm; 2015 Apr 06; 12(4):1171-9. PubMed ID: 25665011
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data.
    Fuchs A, Dressman JB.
    J Pharm Sci; 2014 Nov 06; 103(11):3398-3411. PubMed ID: 25277073
    [Abstract] [Full Text] [Related]

  • 18. In vitro vs. canine data for assessing early exposure of doxazosin base and its mesylate salt.
    Erceg M, Vertzoni M, Cerić H, Dumić M, Cetina-Čižmek B, Reppas C.
    Eur J Pharm Biopharm; 2012 Feb 06; 80(2):402-9. PubMed ID: 22019530
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M, Przyklenk KH, Richtberg A, Baumann W, Dressman JB.
    Eur J Pharm Biopharm; 2014 Nov 06; 88(3):795-806. PubMed ID: 25195981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.